27
Participants
Start Date
June 24, 2014
Primary Completion Date
May 26, 2016
Study Completion Date
May 26, 2016
Ranibizumab
Monthly injections of Intravitreal Ranibizumab 0.3 mg for 12 months in patients previously treated with Avastin for Diabetic Macular Edema.
Ranibizumab
Three Monthly injections of Intravitreal Ranibizumab 0.3 mg in patients previously treated with Avastin for Diabetic Macular Edema. Then follow-up visits may be extended by 2 weeks for a total of 12 months.
Cole Eye Institute at Hillcrest Hospital, Mayfield Heights
Cole Eye Institute, Cleveland Clinic, Cleveland
Lead Sponsor
Collaborators (1)
Genentech, Inc.
INDUSTRY
Justis Ehlers
OTHER